SCHEMBL21370156

SCHEMBL21370156

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccccc4)nc(-c4cc(-c5ccc6c7ccccc7c7ccccc7c6c5)cc(-n5c6ccccc6c6ccccc65)c4)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
MAPT P10636 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
TSPO P30536 1/20 0.33
HDAC4 P56524 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
DHFR P00374 1/20 0.33
NTSR1 P30989 1/20 0.33
PTGER4 P35408 1/20 0.32
LMNA P02545 1/20 0.32
GLA P06280 1/20 0.32
NPY5R Q15761 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21369842 1.00 ATM (0.41) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21370174 0.99 ATM (0.42) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL16904480 0.99 ATM (0.42) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21369790 0.97 ATM (0.39) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21370359 0.97 ATM (0.39) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21370276 0.97 ATM (0.39) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21369843 0.97 KDM4E (0.39) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21370360 0.95 KDM4E (0.37) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21369650 0.95 ATM (0.39) ATML3MBTL1KDM4EMEN1KMT2A
SCHEMBL21370362 0.94 ATM (0.36) ATML3MBTL1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME SOULBRAIN CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190288215-A1 COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 ATM 3568/4885L3MBTL1 1787/4885KDM4E 2473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.